What dose of labetalol (beta blocker) is equivalent to 75 mg of metoprolol tartrate (beta blocker) twice daily (bid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta-Blocker Dose Equivalence: Labetalol to Metoprolol Tartrate

A dose of 200 mg of labetalol twice daily is approximately equivalent to 75 mg of metoprolol tartrate twice daily.

Dose Equivalence Rationale

According to the ACC/AHA guidelines, labetalol and metoprolol have different pharmacological profiles that affect their dosing equivalence 1:

  • Metoprolol tartrate is a selective beta-1 blocker with a recommended dose range of 100-200 mg twice daily for cardiovascular conditions 1
  • Labetalol is a combined alpha- and beta-receptor blocker with a recommended dose range of 200-800 mg twice daily 1

The dose equivalence can be determined by examining their relative potencies and target doses:

Comparative Analysis

  1. Pharmacological differences:

    • Labetalol has both alpha-blocking and beta-blocking properties (ratio of beta:alpha antagonism is 3:1 after oral administration) 2
    • Metoprolol is a selective beta-1 blocker without alpha-blocking effects 1
  2. Target doses in guidelines:

    • Metoprolol tartrate target dose: 100-200 mg twice daily 1
    • Labetalol target dose: 200-800 mg twice daily 1
  3. Clinical comparison studies:

    • Research comparing these medications found that labetalol 200 mg twice daily produced similar beta-blockade effects to metoprolol 50-100 mg twice daily 3, 4
    • The ratio of potency for beta-blockade appears to be approximately 2.5-3:1 (labetalol:metoprolol)

Clinical Considerations

When converting between these medications, consider these important factors:

  • Hemodynamic effects: Labetalol causes less reduction in heart rate than metoprolol at equivalent antihypertensive doses due to its alpha-blocking properties 3
  • Side effect profiles:
    • Labetalol: More likely to cause dizziness, dyspepsia, and nausea 3
    • Metoprolol: More likely to cause bradycardia 3

Dosing Algorithm

  1. For converting from metoprolol tartrate 75 mg BID to labetalol:

    • Initial labetalol dose: 200 mg twice daily
    • Monitor blood pressure and heart rate response
    • Titrate by 100 mg twice daily every 2-3 days as needed
    • Maximum dose: 600 mg twice daily 1
  2. For converting from labetalol to metoprolol tartrate:

    • For every 200 mg of labetalol, use approximately 75 mg of metoprolol tartrate
    • Start at the lower end of the equivalent dose range
    • Titrate based on blood pressure and heart rate response

Important Caveats

  • Individual variability: Patient response may vary significantly based on comorbidities, age, and concurrent medications
  • Gradual transition: When switching between these medications, consider a gradual transition to avoid rebound effects
  • Monitoring: Close monitoring of blood pressure and heart rate is essential during conversion
  • Heart failure patients: In patients with heart failure, metoprolol succinate (extended-release) is preferred over metoprolol tartrate due to more consistent beta-blockade 5

Remember that labetalol's combined alpha- and beta-blocking properties make it particularly useful in situations where peripheral vasodilation is beneficial, while metoprolol's cardioselectivity may be advantageous in patients with reactive airway disease.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.